IMS Faculty Honors

Dr. Cato T. Laurencin to Receive the Kathryn C. Hach Award for Entrepreneurial Success from the American Chemical Society

From UConn Today

Cato LaurencinThe American Chemical Society (ACS) has selected University of Connecticut’s Dr. Cato T. Laurencin as the 2024 recipient of its Kathryn C. Hach Award for Entrepreneurial Success.

As the national awardee, Laurencin is recognized for his use of the transforming power of chemistry to improve people’s lives. The hallmark of this contribution is impact: positive impact on people’s lives and positive impact on the economy by creating jobs that produce a significant economic benefit.

Laurencin’s innovations in regenerative engineering and his impact on the fields of biomaterials, nanotechnology, and stem cell science have had an immeasurable impact. As the leading international figure in polymeric biomaterials chemistry and engineering, he has made not only extraordinary scientific contributions, but has contributed through innovation and invention.

In Connecticut, Laurencin was the lead faculty architect for Bioscience Connecticut. Start-up companies he has founded have led to products now on the market. He received the Connecticut Medal of Technology in recognition of his work in the state.

Nationally, Laurencin is a Fellow of the National Academy of Inventors, and the first surgeon elected to all 4 of the U.S. National Academies. He serves on the board of directors of the National Academy of Inventors and on the National Academy of Inventors Selection Committee.

He received the National Medal of Technology and Innovation, America’ highest recognition for technological achievement, from the President of the United States.  In service to our nation, he serves as Vice-Chair of the National Medal of Technology and Innovation Nomination and Evaluation Committee, appointed by both the Trump and Biden administrations.

Most recently, he received the Inventor of the Year Award presented to the world’s most outstanding recent inventors from the Intellectual Property Owners Education Foundation (IPOEF). The IPOEF’s board of directors voted unanimously for him, recognizing his impact on biomaterials, nanotechnology, stem cell science, and the field of regenerative engineering.

Xiuling Lu Announced as AAPS Fellow

From UConn Today

Dr. Xiuling Lu has been named AAPS fellow.
Dr. Xiuling Lu

Xiuling Lu has attained the esteemed title of AAPS Fellow, a recognition of her steadfast commitment to pioneering research, marked by its unwavering excellence and innovation, and the transformative effects it has had on patients grappling with unmet medical needs.

An AAPS Fellow is an AAPS member who is recognized as a leader in the pharmaceutical field. Peers recognize Fellows for facing challenges head-on with creative solutions in the discovery, development or regulation of pharmaceuticals and biologics.

The status of Fellow denotes professional excellence and a sustained, positive impact to global health and to the AAPS Community. AAPS Fellows are encouraged to continue to actively contribute to their fields and to AAPS throughout their tenure.

Lu stands as a distinguished luminary in the realm of nanoparticle-based therapeutics and their corresponding product advancement. At UConn, her lab has successfully devised inventive image-guided therapeutic nanoparticle systems, surmounting considerable obstacles within the realm of cancer treatment. Lu’s contributions extend further to a profound comprehension of the challenges associated with designing therapeutic agents, enhancing the bedrock understanding of delivery and treatment barriers.

Lu’s engagement encompasses not only the translation of prospective therapeutics to clinical applications but also the commercialization of nanomedicines. Her resolute dedication to scientific advancement and her altruistic endeavors within the community have merited her a multitude of local and national accolades. Lu has served of Chair of the Faculty at the National Institute for Pharmaceutical Technology and Education, and presently holds the mantle of Associate Director at the Center for Pharmaceutical Processing Research, concurrently serving as a leader in the AAPS Nanotechnology Community.